ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 606,37
0,46%
Dow Jones
38 778,10
0,49%
DAX
18 124,61
0,28%
Brent Oil
83,745
-0,18%
Bitcoin
65 242,43
-1,87%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. DermTech Inc (DMTK)

  7. DermTech Inc (DMTK) Actualités

DMTK

DermTech (DMTK)

DermTech Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:DMTK
DateHeureSourceTitreSymboleSociété
13/06/202402h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DMTKDermTech Inc
17/05/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMTKDermTech Inc
14/05/202422h05Business WireDermTech Reports First-Quarter 2024 Financial ResultsNASDAQ:DMTKDermTech Inc
18/04/202422h15Business WireDermTech to Explore Strategic Alternatives and Implement Restructuring PlanNASDAQ:DMTKDermTech Inc
01/04/202422h05Business WireDermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DMTKDermTech Inc
08/03/202414h05Business WireDermTech Presents Research Abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting and New Research Published in the Journal of Investigative DermatologyNASDAQ:DMTKDermTech Inc
07/03/202422h17Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DMTKDermTech Inc
29/02/202422h53Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:DMTKDermTech Inc
29/02/202422h01Business WireDermTech Reports Fourth-Quarter 2023 Financial ResultsNASDAQ:DMTKDermTech Inc
13/02/202414h05Business WireDermTech Announces Release Date for Fourth-quarter 2023 Financial ResultsNASDAQ:DMTKDermTech Inc
31/01/202422h30Business WireDermTech Announces Additional Restructuring Actions to Focus on Revenue Growth and Streamline OperationsNASDAQ:DMTKDermTech Inc
18/01/202414h05Business WireDermTech Announces Positive Topline Results From a Study Evaluating the DermTech Melanoma Test (DMT) Across All Skin TypesNASDAQ:DMTKDermTech Inc
16/01/202414h05Business WireDermTech Simplifies the DermTech Melanoma Test (DMT) by Discontinuing the Optional TERT Add-on AssayNASDAQ:DMTKDermTech Inc
08/01/202414h00Business WireDermTech Announces Positive Topline Results From Trust 2 Study Evaluating the DermTech Melanoma Test (DMT)NASDAQ:DMTKDermTech Inc
04/12/202311h45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of DermTech, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 15, 2023 - (NASDAQ: DMTK)NASDAQ:DMTKDermTech Inc
02/11/202321h31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DMTKDermTech Inc
02/11/202321h01Business WireDermTech Reports Third-Quarter 2023 Financial ResultsNASDAQ:DMTKDermTech Inc
12/10/202314h05Business WireDermTech Announces Release Date for Third-Quarter 2023 Financial ResultsNASDAQ:DMTKDermTech Inc
23/09/202302h43Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:DMTKDermTech Inc
21/09/202322h05Business WireDermTech Grants New CCO Mark Aguillard Inducement Award Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:DMTKDermTech Inc
19/09/202314h05Business WireDermTech Announces Contracts With Highmark for the Foundational Assay of Its DermTech Melanoma Test (DMT)NASDAQ:DMTKDermTech Inc
11/09/202314h05Business WireDermTech Appoints Mark Aguillard as Chief Commercial OfficerNASDAQ:DMTKDermTech Inc
12/08/202300h44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DMTKDermTech Inc
03/08/202322h01Business WireDermTech Reports Second-Quarter 2023 Financial ResultsNASDAQ:DMTKDermTech Inc
19/07/202314h00Business WireDermTech Announces Favorable Coverage Policy With Blues Plan in Michigan for the Foundational Assay of Its DermTech Melanoma Test (DMT)NASDAQ:DMTKDermTech Inc
17/07/202314h00Business WireDermTech Announces Release Date for Second-Quarter 2023 Financial ResultsNASDAQ:DMTKDermTech Inc
13/07/202322h09Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:DMTKDermTech Inc
12/07/202314h00Business WireDermTech Adds Approximately 7 Million Covered Lives for the Foundational Assay of Its DermTech Melanoma Test (DMT)NASDAQ:DMTKDermTech Inc
28/06/202322h30Business WireDermTech Announces Restructuring to Prioritize Growth Opportunities and Streamline OperationsNASDAQ:DMTKDermTech Inc
14/06/202314h00Business WireECRI Completes Evaluation of the Pigmented Lesion Assay (PLA), the Foundational Assay for the DermTech Melanoma Test (DMT)NASDAQ:DMTKDermTech Inc
 Showing the most relevant articles for your search:NASDAQ:DMTK

Dernières Valeurs Consultées

COIN
BCHUSD
Bitcoin Cash
NYSE
IQT
NASDAQI
CRSPMIV1
CRSP US Mid Cap Value
LSE
51RM
First.abu 25
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés